Register Login

Abiopharma

  • Home
  • About
  • Newsroom
  • Company List
  • Events
  • Automated Tools
  • Contact

News list

Pasithea Therapeutics Corp. (KTTAW)

  • Business News
  • June 15, 2026, 11:02 UTC
  • 3
  • 1 comments

Pasithea Therapeutics Announces Exhibit atChildren’s Tumor Foundation 2026 NF Conference

Market reaction Comment Full text

PASITHEA THERAPEUTICS CORP. (KTTA)

  • Business News
  • June 15, 2026, 11:02 UTC
  • 3
  • 1 comments

Pasithea Therapeutics Announces Exhibit at Children’s Tumor Foundation 2026 NF Conference

Market reaction Comment Full text

XORTX Therapeutics Inc (XRTX)

  • Business News
  • June 15, 2026, 11:01 UTC
  • 5
  • 1 comments

XORTX Provides Corporate Update and Announces Appointment of Mika Grasso as Co-CEO

Market reaction Comment Full text

DBS GROUP HOLDINGS LTD (D05)

  • Business News
  • June 15, 2026, 11:00 UTC
  • 4
  • 0 comments

Change - Change in Corporate Information: Liquidation of Indirect Wholly-Owned Subsidiaries

Market reaction Comment Full text

CODA OCTOPUS GROUP, INC. (CODA)

  • Business News
  • June 15, 2026, 11:00 UTC
  • 2
  • 1 comments

Coda Octopus Group Reports Fiscal Second Quarter 2026 Financial Results

Market reaction Comment Full text

AMERICAN EXPRESS CO (AXP)

  • Business News
  • June 15, 2026, 11:00 UTC
  • 2
  • 1 comments

American Express Announces Proposed Acquisition of TheFork, a Leading European Restaurant Booking Platform

Market reaction Comment Full text

TIZIANA LIFE SCIENCES LTD (TLSA)

  • Business News
  • June 15, 2026, 11:00 UTC
  • 3
  • 1 comments

Tiziana Life Sciences Announces Purchase of Shares by Executive Chairman

Market reaction Comment Full text

PEBBLEBROOK HOTEL TRUST (PEB)

  • Business News
  • June 15, 2026, 11:00 UTC
  • 3
  • 1 comments

Pebblebrook Hotel Trust Declares Dividends for Second Quarter 2026

Market reaction Comment Full text

ELICIO THERAPEUTICS, INC. (ELTX)

  • Business News
  • June 15, 2026, 11:00 UTC
  • 4
  • 1 comments

Elicio Therapeutics Reports Results from Phase 2 AMPLIFY-7P Study and Outlines Refined Phase 3 Development Strategy for ELI-002 7P in Adjuvant Pancreatic Cancer

Market reaction Comment Full text

SENTINELONE, INC. (S)

  • Business News
  • June 15, 2026, 11:00 UTC
  • 3
  • 1 comments

Sherritt Announces Exclusivity Agreement with Gillon Capital and Appointment of Independent Director

Market reaction Comment Full text
  • Previous
  • 2915
  • 2916
  • 2917
  • 2918
  • 2919
  • Next

Search

News categories

  • Technical Exchange News(14195)
  • Event(6229)
  • SEC News(363546)
  • FDA Approval(10304)
  • Company Report(721)
  • Business News(223351)
Market reaction

© Copyright Abiopharma. All Rights Reserved
Designed by Alexey Vershinin